UA44385U - Oral cyclodextrin composition - Google Patents
Oral cyclodextrin compositionInfo
- Publication number
- UA44385U UA44385U UAA200600347U UAU200600347U UA44385U UA 44385 U UA44385 U UA 44385U UA A200600347 U UAA200600347 U UA A200600347U UA U200600347 U UAU200600347 U UA U200600347U UA 44385 U UA44385 U UA 44385U
- Authority
- UA
- Ukraine
- Prior art keywords
- oral
- cyclodextrin composition
- consumed
- powder
- tuberculosis
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 abstract 2
- 201000008827 tuberculosis Diseases 0.000 abstract 2
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 229960000285 ethambutol Drugs 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 239000008202 granule composition Substances 0.000 abstract 1
- 229960003350 isoniazid Drugs 0.000 abstract 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 abstract 1
- 229940042126 oral powder Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229960005206 pyrazinamide Drugs 0.000 abstract 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 abstract 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 abstract 1
- 229960001225 rifampicin Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A stabilized oral powder or granule mixture made from at least two different antimicrobial tuberculosis drugs (e.g. rifampicin, isoniazid, ethambutol, pyrazinamide), for a short-course therapy; the powder can be consumed by mixing in a glass of water or juice and assures that each of the various drugs is in fact consumed by the tuberculosis patient.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN124MU2004 | 2004-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA44385U true UA44385U (en) | 2009-10-12 |
Family
ID=34835543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200600347U UA44385U (en) | 2004-02-04 | 2004-06-18 | Oral cyclodextrin composition |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1711182A1 (en) |
| BR (1) | BRPI0415338A (en) |
| UA (1) | UA44385U (en) |
| WO (1) | WO2005074937A1 (en) |
| ZA (1) | ZA200600783B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3942C2 (en) * | 2009-01-22 | 2010-02-28 | Институт Химии Академии Наук Молдовы | Iron and cobalt complexes with 2-furoic acid possessing antituberculous properties |
| WO2012013756A2 (en) | 2010-07-28 | 2012-02-02 | Laboratoires Pharma 5 | Method for preparing tablets combining rifampicin, isoniazid, pyrazinamide and, optionally, ethambutol |
| AU2014295100B2 (en) * | 2013-07-26 | 2019-01-03 | Sanofi | Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02300140A (en) * | 1989-05-12 | 1990-12-12 | Yamanouchi Pharmaceut Co Ltd | Cyclodextrin clathrate body of drug and production thereof |
| CN1029080C (en) * | 1992-06-26 | 1995-06-28 | 佛冈县新技术研究开发部 | Rifampin paste preparing process |
| BR0116994A (en) * | 2001-04-27 | 2004-03-02 | Lupin Ltd | An improved process for preparing a composition comprising a fixed dose combination (fdc) of four antituberculosis drugs |
| US7001893B2 (en) * | 2002-10-28 | 2006-02-21 | Council Of Scientific And Industrial Research | Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof |
-
2004
- 2004-06-18 WO PCT/IN2004/000178 patent/WO2005074937A1/en not_active Application Discontinuation
- 2004-06-18 BR BRPI0415338-3A patent/BRPI0415338A/en not_active Application Discontinuation
- 2004-06-18 UA UAA200600347U patent/UA44385U/en unknown
- 2004-06-18 EP EP04806723A patent/EP1711182A1/en not_active Withdrawn
-
2006
- 2006-01-03 ZA ZA200600783A patent/ZA200600783B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0415338A (en) | 2006-12-05 |
| EP1711182A1 (en) | 2006-10-18 |
| ZA200600783B (en) | 2007-02-28 |
| WO2005074937A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| TW200504053A (en) | Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders | |
| TW200738735A (en) | Oxygen linked pyrimidine derivatives | |
| TW200630326A (en) | Chemical compounds | |
| MY191349A (en) | New pharmaceutical compositions for the treatment of hyper-proliferative disorders | |
| WO2007149406A8 (en) | Modified coagulation factor ix polypeptides and use thereof for treatment | |
| TW200508214A (en) | Novel compounds | |
| SG170069A1 (en) | Quinoline derivatives | |
| TN2009000111A1 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
| WO2005118601A3 (en) | Sulfonylethyl phosphorodiamidates for use in the treatment of cancer | |
| HK1086832A1 (en) | Substituted benzosulphonamides as potentiators of glutamate receptors | |
| DE502005005636D1 (en) | Spirocyclische cyclohexan-derivate | |
| MXPA05009103A (en) | 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders. | |
| MXPA05013637A (en) | Gsk-3 inhibitors and uses thereof. | |
| MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| PL1654253T3 (en) | Substituted 3-pyrrolidin-indole derivatives | |
| TW200630352A (en) | Chemical compounds | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| UA88941C2 (en) | Substituted 4-phenyltetrahydroisoquinolines, their use as drug, and drug containing them | |
| WO2004078748A3 (en) | Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders | |
| EP1812112A4 (en) | Chemical compounds | |
| MXPA05011785A (en) | Positive modulators of nicotinic acetylcholine receptors. | |
| WO2007075650A3 (en) | Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders | |
| UA44385U (en) | Oral cyclodextrin composition | |
| TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents |